California Votes to Ban Sale of Flavored Tobacco Products

Nov.10.2022
California Votes to Ban Sale of Flavored Tobacco Products
California voters support a law to end the sale of flavored tobacco products, including e-cigarettes and flavored cigars.

Californians have voted in support of a state government law to end the sale of most flavored tobacco products, including flavored e-cigarettes, menthol cigarettes, and flavored cigars.


On November 9th, Proposition 31, which upholds the law, was leading with a 65% to 35% advantage. According to the Associated Press, official results will take more time to be confirmed. The state mailed ballots to all active voters and ballots postmarked on Election Day have a week to arrive.


In 2020, California lawmakers passed a ban prohibiting all flavored nicotine products except for hookah, loose-leaf tobacco (used for pipes), and premium cigars. Mint-flavored products are also included in the legislation.


The Proposition 31 is the antidote to the candy-flavored poison that big tobacco companies sell to our children and communities of color in California," said Jerry Hill, the author of the original bill that became Proposition 31 and former senator. "With the implementation of Proposition 31, there is now a strong defense against tobacco companies' ability to lure children into smoking and a lifelong addiction to nicotine; Californians will live longer and healthier because of this.


Opponents of the ban collected over a million signatures, forcing the state to hold a referendum on the issue. The legislation, originally slated to take effect on January 1, 2021, was subsequently suspended until the vote on November 8.


Advocates of Proposal 31 argue that these restrictions will prevent children from using tobacco by eliminating flavors such as bubblegum, cotton candy, and cherry that are popular among young people.


Opponents argue that the ban will eliminate electronic nicotine delivery systems, which they see as an effective tool in the effort to quit traditional smoking, and unfairly target certain communities. For instance, black smokers are more likely to use menthol cigarettes.


Supporters of the ban had a significant lead over opponents prior to the vote. According to the San Francisco Chronicle, as of mid-October, billionaire anti-smoking and anti-vaping activist Michael Bloomberg had contributed $15.3 million of the $17.3 million raised by the committee supporting the ban. In contrast, opponents had raised just over $2 million, with nearly all of it coming from donations by Philip Morris USA ($1.2 million) and R.J. Reynolds ($743,000).


California, along with Massachusetts and Washington D.C., has banned the sale of flavored tobacco products, including flavored e-cigarettes, menthol cigarettes, and flavored cigars. Three other states - New Jersey, New York, and Rhode Island - have also banned the sale of flavored e-cigarettes. With local laws included, 25% of the U.S. population is now covered by laws ending the sale of flavored e-cigarettes.


Statement:


This article is compiled from third-party information and is only intended for industry exchange and learning purposes.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the truthfulness or accuracy of its contents. The compilation of this article is only intended for industry-related research and communication purposes.


Due to limitations in our translation abilities, the translated article may not fully reflect the original text. Please refer to the original article for accurate information.


2FIRSTS fully aligns with the Chinese government's stances and statements on domestic, Hong Kong, Macau, Taiwan, and international matters.


The copyright of the compiled information belongs to the original media and authors. If there is any infringement, please contact us to have it removed.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Couche-Tard Posts Double-Digit U.S. Same-Store Growth in Other Nicotine Products, Led by Pouches
Couche-Tard Posts Double-Digit U.S. Same-Store Growth in Other Nicotine Products, Led by Pouches
Alimentation Couche-Tard said U.S. same-store sales in its “other nicotine products” category grew at a double-digit rate in the first quarter of fiscal 2027, led by nicotine pouches, while overall U.S. same-store merchandise revenues increased 1.7%. The company also said its Canadian nicotine business continued to face regulatory pressure and illicit-market headwinds. The U.S. performance coincides with Couche-Tard's participation in efforts to reopen Canadian convenience-store access to authorized nicotine pouches, though the company has not established a direct causal link between the two.
Sep.14
As Regulators Focus on Nicotine Pouch Child Safety, Safeguard Pursues an External Packaging Route
As Regulators Focus on Nicotine Pouch Child Safety, Safeguard Pursues an External Packaging Route
As regulators pay closer attention to child safety in nicotine pouches, manufacturers face a practical challenge: how to strengthen child-resistant packaging without unnecessarily reworking products, production lines and regulatory submissions already in place. In a written interview with 2Firsts, Chemular detailed Safeguard’s external packaging approach, its customer-specific testing requirements and possible PMTA pathways. The model remains early-stage, but it offers a new way to think about an increasingly important regulatory and manufacturing issue.
Industry Insight
Sep.19
German Customs Seize 115,800 Vapes in €1.4 Million Tax Case
German Customs Seize 115,800 Vapes in €1.4 Million Tax Case
Germany's Magdeburg Main Customs Office seized 115,800 untaxed e-cigarettes containing a combined 4.366 million mL of e-liquid during four truck inspections between August 10 and September 4, 2026. The seizures prevented an estimated €1.397 million in tax losses and set a record for the customs office's jurisdiction. Criminal proceedings have been initiated against four truck drivers. The case follows a separate German investigation involving more than 7.6 million illicit vapes and an estimated €33.3 million in excise-tax losses.
Enforcement
Oct.13
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane’s 2026 update of its living review on electronic cigarettes for smoking cessation included 80 randomized controlled trials involving 29,861 adult smokers, with nine trials added in this update. The review retained its high-certainty conclusion that nicotine e-cigarettes increase smoking cessation rates compared with nicotine replacement therapy. In absolute terms, about 10 in 100 people using nicotine e-cigarettes may quit smoking for at least six months, compared with about 6 in 100 using NRT. The review found no clear difference in serious adverse event rates between the two groups, while longer-term safety and the relative effectiveness of newer device types remain less certain.
Sep.07
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
FDA’s Center for Tobacco Products is reshaping how it approaches tobacco product review. Based on 2Firsts’ on-site reporting in New York and Washington, this report traces CTP’s emerging direction: stronger links between PMTA and tobacco harm reduction, more category-specific review, greater emphasis on decision-relevant science, more predictable timelines and expanded use of sPMTA for product modifications. CTP also acknowledged major constraints, including just nine PMTA review teams, persistent backlogs and limits on hiring capacity.
Regulations
Oct.08
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
At the 2026 New Approaches Summit in New York, former FDA Center for Tobacco Products Director Mitch Zeller called for the tobacco harm reduction debate to shift from the traditional “end game” toward defining a desired “end state.” He also highlighted unresolved concerns around dual use, argued that biomarkers of exposure may be more meaningful than cigarettes-per-day in assessing risk reduction, and said nicotine misperceptions remain a major barrier to public health progress.
Sep.25